In my opinion, the biggest news from #AHA22 for the heart failure community was the results of #STRONGHF. @AlexMebazza, the trial's principal investigator, presented the results. The following thread summarizes his presentation. @AHAScience#STRONGHF was conducted to determine whether rapid/high-intensity uptitrations of doses of heart failure #GDMT would be safe and effective compared with usual care. @AlexMebazaa@AHAScience#AHA22
Apr 18, 2020 • 6 tweets • 3 min read
#HFpEF was a hot topic this morning at @CanHFSociety#HFupdate20! Dr. @KSharmaMD of @HopkinsMedicine spoke on the process of making a correct HFpEF diagnosis - something which most internists and even cardiologists struggle with according to data which was shared. 1/6
In the "real world" @KSharmaMD makes her diagnosis by identifying patients with a clinical heart failure syndrome, LVEF > 50% and objective evidence of cardiac disease (⬆️BNP, LVH, diastolic dysfunction, PCWP or LVEDP > 15). Dr. Sharma also alerted us to be mindful of the 2/6